INTENSITY THERAPEUTICS, INC. Cash
INTENSITY THERAPEUTICS, INC. (INTS) had Cash of $474.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-08-11
- 2026-06-30: Cash $474.00K.
- 2026-03-31: Cash $867.00K.
- 2025-12-31: Cash $86.00K.
- 2025-09-30: Cash $709.00K.
| Period end | Cash |
|---|---|
| 2026-06-30 | $474.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $867.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $86.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $709.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $118.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $94.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $428.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $322.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $434.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $3.41M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $367.00K 10-K · filed 2025-03-13 |
| 2023-03-31 | $367.00K 10-Q · filed 2024-05-09 |
| 2022-12-31 | $1.31M 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |